Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 6, 2015, Pages 1880-1885

  Feng, Ning ^a   Huke, Sabine ^b   Zhua, Guangshuo ^a   Tocchetti, Carlo G ^c   Shi, Sa ^a   Aiba, Takeshi ^d   Kaludercice, Nina ^e   Hooverf, Donald B ^f   Beckg, Sarah E ^a   Mankowskig, Joseph L ^a   Tomaselli, Gordon F ^a   Bersh, Donald M ^g   Kassa, David A ^a   Paoloccia, Nazareno ^a,h  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Clinica Montevergine   (Italy)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e CNR   (Italy)

^f East Tennessee State University   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; HEART CONTRACTION; HEART HEMODYNAMICS; HEART INNERVATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART VENTRICLE PRESSURE; HEART VOLUME; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; CALCIUM SIGNALING; DIASTOLE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM; CALCIUM SIGNALING; DIASTOLE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; PATCH-CLAMP TECHNIQUES; RECEPTOR, TRKB;

EID: 84922665700     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1417949112     Document Type: Article

References (28)

1. Lu B, Nagappan G, Guan X, Nathan PJ, Wren P (2013) BDNF-based synaptic repair as a dis-ease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14(6):401-416.
2. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci 7(2):137-151.
3. Abcejo AJ, et al. (2012) Brain-derived neurotrophic factor enhances calcium regulatory mechanisms in human airway smooth muscle. PLoS ONE 7(8):e44343.
4. Marosi K, Mattson MP (2014) BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25(2):89-98.
5. Donovan MJ, et al. (2000) Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127(21):4531-4540.
6. Yang B, Slonimsky JD, Birren SJ (2002) A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nat Neurosci 5(6):539-545.
7. Kermani P, Hempstead B (2007) Brain-derived neurotrophic factor: A newly described mediator of angiogenesis. Trends Cardiovasc Med 17(4):140-143.
8. Okada S, et al. (2012) Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arterioscler Thromb Vasc Biol 32(8):1902-1909.
9. Caporali A, Emanueli C (2009) Cardiovascular actions of neurotrophins. Physiol Rev 89(1):279-308.
10. Chen X, et al. (2005) A chemical-genetic approach to studying neurotrophin signaling. Neuron 46(1):13-21.
11. Bishop AC, et al. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407(6802):395-401.
12. Liu Y, et al. (2012) Sexually dimorphic BDNF signaling directs sensory innervation of the mammary gland. Science 338(6112):1357-1360.
13. Chao MV (2003) Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat Rev Neurosci 4(4):299-309.
14. Huke S, Bers DM (2008) Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem Biophys Res Commun 376(1):80-85.
15. Mattiazzi A, Kranias EG (2011) CaMKII regulation of phospholamban and SR Ca2+ load. Heart Rhythm 8(5):784-787.
16. Adams JW, et al. (1998) Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95(17):
17. Eide FF, et al. (1996) Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci 16(10): 3123-3129.
18. Vidaurre OG, et al. (2012) Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity. Cell Death Dis 3:e256.
19. Wong J, Rothmond DA, Webster MJ, Weickert CS (2013) Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia. Schizophr Bull 39(1):130-140.
20. Mishra S, et al. (2010) Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol 56(6):598-603.
21. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8(8):457-465.
22. Pedersen BK, et al. (2009) Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol 94(12): 1153-1160.
23. Takashio S, et al. (2013) Abstract 12400: Significant Association between Decreased Plasma Levels of Brain-derived Neurotrophic Factor in Heart Failure. Circulation 128(Supplement 22):A12400.
24. Fukushima A, et al. (2013) Decreased serum brain-derived neurotrophic factor levels are correlated with exercise intolerance in patients with heart failure. Int J Cardiol 168(5):e142-e144.
25. Cittadini A, et al. (1998) Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles. Circ Res 83(1):50-59.
26. Rottbauer W, et al. (2005) VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart. Genes Dev 19(13):1624-1634.
27. Force T, Kolaja KL (2011) Cardiotoxicity of kinase inhibitors: The prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov 10(2): 111-126.
28. Anderson ME, Brown JH, Bers DM (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51(4):468-473.